Pictet Asset Management
ICPT

Pictet Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Pictet Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,205,093
Closed -$22.3M – 2039
2023
Q3 		$22.3M Buy
+1,205,093
New +$13.6M 0.03% 430

Pictet Asset Management's ICPT Position: Q4 2023 in Review

Pictet Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 1,205,093 shares — an estimated $22.3M sold.

Pictet Asset Management first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $22.3M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Pictet Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Pictet Asset Management sold 1,205,093 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $22.3M.
  • Pictet Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
  • Pictet Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $22.3M in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Pictet Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.